DOCN EBITDA Growth
34.51%TTM
Period ending:
DOCN TTM EBITDA YoY %%
182.65%-17.58%
2021-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
DOCN ebitda growth history
Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 19 observations from Dec 31, 2021 to Jun 30, 2026.
| Period ending | EBITDA Growth |
|---|---|
| 34.5115% | |
| 40.1848% | |
| 51.3354% | |
| 52.9374% | |
| 23.5561% | |
| 31.4083% | |
| 54.2214% | |
| 78.9927% | |
| 148.418% | |
| 163.277% | |
| 85.0134% | |
| 58.3624% | |
| 43.6176% | |
| 18.3192% | |
| 12.3101% | |
| 11.948% | |
| 1.8004% | |
| 1.8303% | |
| 58.8647% |
Compare ebitda growth
All DOCN financial metrics · DOCN stock overview · How to interpret financial metrics
